Skip to main content
OpenTrials

Clinical trial condition

Relapsed/Refractory (R/R) Angioimmunoblastic T-cell Lymphoma (AITL)

Explore clinical trials studying Relapsed/Refractory (R/R) Angioimmunoblastic T-cell Lymphoma (AITL). Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study
Refine in advanced search Browse all conditions

Relapsed/Refractory (R/R) Angioimmunoblastic T-cell Lymphoma (AITL) trial results

Recruiting

A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.

NCT06393738

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +15 more
Locations
  • Clinical Trial Site New Haven, Connecticut, United States
  • Clinical Trial Site Detroit, Michigan, United States
  • Clinical Trial Site New Brunswick, New Jersey, United States
  • Clinical Trial Site New York, United States
View all 17 locations
View Trial Details

Related conditions